Raltegravir Potassium

BH3 interacting domain death agonist ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29771789 Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial. 2018 Aug 15 1
2 22252825 Pharmacokinetics of and short-term virologic response to low-dose 400-milligram once-daily raltegravir maintenance therapy. 2012 Apr 1
3 20974575 Simplification from protease inhibitors to once- or twice-daily raltegravir: the ODIS trial. 2010 Jul-Aug 1